Abstract

Limited data exist on ECMO at the time of LTx in children. The UNOS database was queried from 2000 to 2013 for pediatric lung transplant recipients (<18yr) to assess post-transplant survival of patients on ECMO at the time of LTx. Of 587 pediatric recipients with 17 on ECMO, 585 were used for univariate and Kaplan-Meier function analysis, 535 for multivariate Cox models, and 24 for propensity score matching. Univariate Cox (HR=1.777; 95% CI: 0.658, 4.803; p=0.257) and Kaplan-Meier function (log-rank test: chi-square (df=1): 1.32, p=0.250) analyses did not identify a survival difference between ECMO and non-ECMO, while multivariate Cox models (HR=1.821; 95% CI: 0.654, 5.065; p=0.251) did not demonstrate an increased risk for death. Propensity score matching analysis (HR=1.500; 95% CI: 0.251, 8.977; p=0.657) also failed to demonstrate a significantly increased hazard ratio. Using a contemporary cohort of pediatric lung transplant recipients, the use of ECMO at the time of lung transplantation did not negatively impact survival.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call